Latest Breaking News On - Regulatory affairs at pfizer - Page 1 : comparemela.com

/PRNewswire/ Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an.

David rosenBriggsw morrisonRegado biosciencesMelissa forstMichaela metzgerGlobal medicines developmentHead of researchCompany on twitterSyndax pharmaceuticalsMerck coUniversity of connecticutYork university stern school of businessGeorge washington universityGeorgetown universityRegulatory affairs at pfizerCompany board of directors